{"brief_title": "Safety and Effectiveness of Zemplar Injection in Decreasing iPTH Levels in Pediatric ESRD Subjects on Hemodialysis", "brief_summary": "The purpose of this study is to see if Zemplar, a vitamin D medication, safely and effectively decreases parathyroid hormone in children ages 2-20 with End Stage Renal Disease.", "condition": ["Secondary Hyperparathyroidism", "End Stage Renal Disease"], "intervention_type": ["Drug"], "intervention_name": ["paricalcitol injection"], "criteria": "Subjects ages 2-20 with ESRD on hemodialysis with Secondary hyperparathyroidism", "gender": "All", "minimum_age": "2 Years", "maximum_age": "20 Years", "healthy_volunteers": "No", "mesh_term": ["Kidney Failure, Chronic", "Hyperparathyroidism", "Hyperparathyroidism, Secondary"], "id": "NCT00053547"}